DENTSPLY SIRONA INC

Insider buying continues at DENTSPLY SIRONA: non‑executive Jonathan Jay Mazelsky’s recent purchase of 10,000 shares signals confidence amid a flat market and offers investors a nuanced view of the dental‑care company’s prospects.

Insider buying surge at DENTSPLY SIRONA signals strong confidence in its dental tech pipeline—high‑dose‑reduced imaging, 12% better implant survival, and 20% faster procedures—boosting future growth potential.

Insider buying at DENTSPLY SIRONA signals confidence amid a 32 % share decline, highlighting growth potential in implants and imaging despite negative earnings.

Insider buying at DENTSPLY SIRONA signals potential upside: director Lucier Gregory T.’s largest share purchase shows confidence amid a low price, negative P/E, and strong dental‑equipment fundamentals. Explore why this could spur a rebound.

Insider buying spurs optimism for DENTSPLY SIRONA amid dental‑equipment sector shifts, highlighting management confidence, digital‑health growth, and market‑share gains.

Andrea Frohning’s 5,957‑share sale at DENTSPLY SIRONA is routine tax‑covering activity, leaving long‑term investors a solid dental‑tech play amid steady gains and no major volatility.

Insider buys of DENTSPLY SIRONA signal bullish momentum—highlighting a strategic edge, rising social buzz, and potential mid‑term upside amid earnings optimism.

Discover how Dentsply Sirona’s insider buying signals bullish growth and investor confidence amid market volatility.

Insight: DENTSPLY SIRONA’s CEO’s latest tax‑cover sale is routine, not a warning. The article explains how insider buying, governance moves, and a solid growth strategy keep the company on track.

Insider buying surge at DENTSPLY SIRONA signals confidence: CEO and executives purchase 1.1 M shares, expecting a rebound and long‑term value creation.